What's-your-source?Email-from-T/A,or show-in-filings/PR?Too much nonsense pro+con floating around: "FDA approval tomorrow," "they will have 2B shares again in a month," that doesn't help anyone. If this is based on documentation pls. show, otherwise we assume everything is just opinions.
It's not hard to quote from the filings or copy and paste a T/A email (that is not privileged information, to the contrary).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.